GLP-1 drugs: what Idaho Medicaid paid

Q: Does a paid prescription mean Idaho Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Idaho Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Idaho Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Idaho Medicaid’s payment record shows

In 2026Q1, the product Idaho Medicaid paid for most often was Ozempic®, at 7,371 prescriptions¹⁹ of the 11,171 to 11,261^{1,7,13,19,25,37} across all 8 products, or 66 percent of the published count.

Idaho Medicaid itself reimbursed at least $11,116,736 for these products in the quarter, about $996 per prescription. Pharmacies were paid $11,257,332 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,272.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Idaho Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Idaho Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Idaho Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Idaho Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	997¹	9%	$1,052,858	$1,056,547	$1,056
tirzepatideMounjaro®	Fee-for-service	at least 2,417⁷	22%	$2,551,229	$2,596,162	$1,056
semaglutideWegovy®	Fee-for-service	171¹³	2%	$217,431	$223,626	$1,272
semaglutideOzempic®	Fee-for-service	7,371¹⁹	66%	$7,117,185	$7,200,226	$966
semaglutideRybelsus®	Fee-for-service	141²⁵	1%	$137,491	$140,016	$975
liraglutideSaxenda®	Not published	No row	n/a	Not published	Not published	Not published
liraglutideVictoza®	Fee-for-service	64³⁷	<1%	$40,542	$40,755	$633
liraglutideliraglutide (generic)	Fee-for-service	Withheld	n/a	Not published	Not published	Not published

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 64 against 1,055. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 37.9 to 38.2 prescriptions per thousand people enrolled in Idaho Medicaid, on an average of 294,691 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 6 of the 168 product-quarters it holds a row for here, which is 4 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Across every quarter on file, the federal record holds no row at all for Saxenda®. That is an absence in the file rather than a refusal by Idaho Medicaid: no prescription was reported, and the reason is not published here.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Idaho Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Idaho Medicaid paid for each product, quarter by quarter

Prescriptions Idaho Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®range 727 to 997, up 270 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	at least 32 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$33,975 paid	at least 250 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$265,079 paid	at least 660 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$695,817 paid	727 paid prescriptions in the quarter (2025Q4)²Count$765,258 paid	997 paid prescriptions in the quarter (2026Q1)¹Count$1,052,858 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	at least 36 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$34,494 paid	at least 57 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$56,202 paid	at least 115 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$112,478 paid	at least 214 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$207,567 paid	462 paid prescriptions in the quarter (2023Q3)¹⁰Count$450,639 paid	at least 751 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$737,944 paid	at least 925 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$951,441 paid	at least 1,184 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$1,213,352 paid	at least 1,857 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$1,898,532 paid	at least 2,268 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$2,297,079 paid	at least 2,847 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$2,923,201 paid	at least 2,790 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$2,880,836 paid	at least 2,801 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$2,919,886 paid	at least 2,385 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$2,474,254 paid	at least 2,417 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$2,551,229 paid
semaglutideWegovy®range 143 to 194, up 28 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable¹⁵Withheld2 of 2 product codes withheld	at least 28 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$34,232 paid	at least 113 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$145,649 paid	144 paid prescriptions in the quarter (2025Q1)¹⁴Count$187,183 paid	143 paid prescriptions in the quarter (2025Q2)¹⁴Count$186,233 paid	194 paid prescriptions in the quarter (2025Q3)¹⁴Count$252,789 paid	143 paid prescriptions in the quarter (2025Q4)¹⁴Count$182,317 paid	171 paid prescriptions in the quarter (2026Q1)¹³Count$217,431 paid
semaglutideOzempic®range 6,873 to 8,844	at least 1,716 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$1,412,037 paid	at least 2,175 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$1,804,150 paid	at least 2,919 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$2,442,385 paid	at least 3,445 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$2,876,444 paid	at least 4,116 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$3,537,507 paid	at least 5,152 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$4,398,906 paid	at least 6,178 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$5,271,376 paid	at least 6,376 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$5,426,469 paid	8,844 paid prescriptions in the quarter (2023Q1)²²Count$7,830,858 paid	at least 10,571 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$9,381,689 paid	at least 9,472 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$8,664,744 paid	at least 9,028 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$8,365,437 paid	at least 9,882 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$9,329,359 paid	at least 8,845 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$8,369,850 paid	7,456 paid prescriptions in the quarter (2024Q3)²¹Count$7,051,578 paid	6,976 paid prescriptions in the quarter (2024Q4)²¹Count$6,613,116 paid	7,059 paid prescriptions in the quarter (2025Q1)²⁰Count$6,860,784 paid	6,873 paid prescriptions in the quarter (2025Q2)²⁰Count$6,687,028 paid	6,900 paid prescriptions in the quarter (2025Q3)²⁰Count$6,715,414 paid	at least 6,831 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$6,505,749 paid	7,371 paid prescriptions in the quarter (2026Q1)¹⁹Count$7,117,185 paid
semaglutideRybelsus®range 110 to 274, down 5 on the quarter before	at least 40 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$32,473 paid	at least 74 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$58,519 paid	110 paid prescriptions in the quarter (2021Q3)³⁰Count$89,183 paid	at least 99 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$80,052 paid	at least 118 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$97,574 paid	at least 153 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$130,537 paid	at least 175 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$149,536 paid	at least 219 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$186,546 paid	at least 269 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$230,828 paid	240 paid prescriptions in the quarter (2023Q2)²⁸Count$216,634 paid	241 paid prescriptions in the quarter (2023Q3)²⁸Count$218,984 paid	274 paid prescriptions in the quarter (2023Q4)²⁸Count$245,947 paid	255 paid prescriptions in the quarter (2024Q1)²⁷Count$236,481 paid	248 paid prescriptions in the quarter (2024Q2)²⁷Count$230,842 paid	238 paid prescriptions in the quarter (2024Q3)²⁷Count$222,773 paid	202 paid prescriptions in the quarter (2024Q4)²⁷Count$189,659 paid	207 paid prescriptions in the quarter (2025Q1)²⁶Count$202,493 paid	191 paid prescriptions in the quarter (2025Q2)²⁶Count$192,337 paid	184 paid prescriptions in the quarter (2025Q3)²⁶Count$179,704 paid	146 paid prescriptions in the quarter (2025Q4)²⁶Count$142,326 paid	141 paid prescriptions in the quarter (2026Q1)²⁵Count$137,491 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 33 to 1,055, up 18 on the quarter before	1,055 paid prescriptions in the quarter (2021Q1)⁴²Count$880,516 paid	987 paid prescriptions in the quarter (2021Q2)⁴²Count$819,035 paid	1,018 paid prescriptions in the quarter (2021Q3)⁴²Count$846,246 paid	911 paid prescriptions in the quarter (2021Q4)⁴²Count$765,850 paid	879 paid prescriptions in the quarter (2022Q1)⁴¹Count$764,664 paid	837 paid prescriptions in the quarter (2022Q2)⁴¹Count$721,298 paid	752 paid prescriptions in the quarter (2022Q3)⁴¹Count$651,423 paid	680 paid prescriptions in the quarter (2022Q4)⁴¹Count$586,551 paid	760 paid prescriptions in the quarter (2023Q1)⁴⁰Count$689,616 paid	598 paid prescriptions in the quarter (2023Q2)⁴⁰Count$534,923 paid	467 paid prescriptions in the quarter (2023Q3)⁴⁰Count$424,252 paid	401 paid prescriptions in the quarter (2023Q4)⁴⁰Count$358,204 paid	374 paid prescriptions in the quarter (2024Q1)³⁹Count$264,415 paid	281 paid prescriptions in the quarter (2024Q2)³⁹Count$197,002 paid	201 paid prescriptions in the quarter (2024Q3)³⁹Count$128,404 paid	172 paid prescriptions in the quarter (2024Q4)³⁹Count$113,586 paid	108 paid prescriptions in the quarter (2025Q1)³⁸Count$63,336 paid	33 paid prescriptions in the quarter (2025Q2)³⁸Count$19,204 paid	43 paid prescriptions in the quarter (2025Q3)³⁸Count$27,947 paid	46 paid prescriptions in the quarter (2025Q4)³⁸Count$31,918 paid	64 paid prescriptions in the quarter (2026Q1)³⁷Count$40,542 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable⁴⁵Withheld1 of 1 product codes withheld	at least 18 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$8,916 paid	at least 33 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$18,972 paid	at least 30 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$14,569 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable⁴⁴Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable⁴³Withheld8 of 8 product codes withheld

What this page cannot tell you

Whether Idaho Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Idaho in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, ID
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state ID, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ID", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "283"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, ID
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state ID, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "273"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, ID
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state ID, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like ZEPBOUND%, state ID, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, ID
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state ID, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like ZEPBOUND%, state ID, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, ID
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state ID, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like ZEPBOUND%, state ID, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, ID
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state ID, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like ZEPBOUND%, state ID, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, ID
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state ID, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ID", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "600"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, ID
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state ID, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "700"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, ID
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state ID, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "545"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, ID
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state ID, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "231"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, ID
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state ID, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "39"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, ID
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state ID, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like MOUNJARO%, state ID, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, ID
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state ID, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ID", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "47"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, ID
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state ID, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "54"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, ID
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state ID, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "42"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, ID
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state ID, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like WEGOVY%, state ID, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, ID
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state ID, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like WEGOVY%, state ID, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, ID
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state ID, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like WEGOVY%, state ID, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, ID
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state ID, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ID", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "2749"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, ID
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state ID, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "2542"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, ID
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state ID, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3901"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, ID
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state ID, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "4183"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, ID
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state ID, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3359"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, ID
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state ID, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "2003"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, ID
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state ID, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ID", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "72"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, ID
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state ID, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "109"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, ID
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state ID, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "109"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, ID
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state ID, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "139"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, ID
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state ID, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "107"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, ID
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state ID, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2021", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "65"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, ID
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state ID, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like SAXENDA%, state ID, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, ID
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state ID, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like SAXENDA%, state ID, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, ID
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state ID, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like SAXENDA%, state ID, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, ID
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state ID, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like SAXENDA%, state ID, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, ID
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state ID, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like SAXENDA%, state ID, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, ID
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state ID, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like SAXENDA%, state ID, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, ID
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state ID, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ID", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "35"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, ID
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state ID, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "64"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, ID
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state ID, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "216"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, ID
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state ID, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "427"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, ID
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state ID, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2022", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "500"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, ID
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state ID, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2021", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "581"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, ID
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state ID, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "ID", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, ID
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state ID, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "22"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, ID
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state ID, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, ID
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state ID, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like LIRAGLUTID%, state ID, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, ID
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state ID, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like LIRAGLUTID%, state ID, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, ID
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state ID, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "ID", "product_name": "product_name like LIRAGLUTID%, state ID, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 31 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 17 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Idaho Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.